Neutrophil biology modulator(Enveda)

N/A

Report date: 2023/09/18 16:39:20
NME

Base Information

Drug NameNeutrophil biology modulator(Enveda)
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsInflammationIdiopathic Pulmonary Fibrosis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesEnveda Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesEnveda Therapeutics Inc
Inactive CompaniesN/A
Active IndicationsInflammationIdiopathic Pulmonary Fibrosis
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A